World Business Report cover image

Would US drug prices drop?

World Business Report

00:00

Industry R&D Costs vs. Patient Access

Andrew Mulcahy discusses drug development costs, blockbuster returns, and the trade-off between R&D revenue and patient affordability.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app